Accès ouvert
2026
article
OpenAlex
Mustafa Yalçınkaya, Cheng-Chieh Hsu, Linke Li, Ranran Wang et autres
BACKGROUND: Clonal hematopoiesis (CH) arising from mutations in hematopoietic genes has been identified as an important risk factor for atherosclerotic cardiovascular disease. Despite the established role of some CH mutations in promoting atherosclerosis progression, their role in clinically relevant LDL (low-density lipoprotein) …
us, it
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
Runfeng Zhang, Hong Yu, Miao Chen, Xiaoqi Qin et autres
cn
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
Limin Hong, Hangfei Wang, Xiyuan Lin, Bo Sun et autres
Reperfusion therapies following stroke can contribute to further brain injury.Inhibition of G9a has been demonstrated to increase BDNF expression, thereby exerting neuroprotective effects. Isoquercetin (ISO) has shown neuroprotective potential, but its molecular mechanisms are not fully known. This study aimed to investigate …
cn
(code pays fourni par la source)
Accès ouvert
2026
conference-paper
OpenAlex
Miao Chen, Baoqiang Li
cn
(code pays fourni par la source)
2026
article
OpenAlex
Ziqi Liu, Manzhen Li, Pengxin Li, Miao Chen et autres
cn
(code pays fourni par la source)
2025
article
OpenAlex
Wenxiang Xia, Miao Chen, Yuyuan Huang, Xin Ji et autres
cn
(code pays fourni par la source)
2025
article
OpenAlex
Aiping Wang, Miao Chen, Haifeng Hu
Using panel data from China’s A-share listed manufacturing firms (2012–2022), this study examines whether supply chain finance (SCF) promotes collaborative innovation, measured by joint patents. Regression results reveal that SCF engagement doubles collaborative innovation output by alleviating financing constraints, optimizing trust relationships, …
cn
(code pays fourni par la source)
Accès ouvert
2025
conference-abstract
OpenAlex
Xijuan Lin, Ziwei Liu, Chen Yang, Junling Zhuang et autres
Abstract Abstract Background: Current therapeutic strategies for Myelodysplastic/Myeloproliferative Neoplasms overlap syndromes (MDS/MPN) remain suboptimal. Selinexor, an innovative oral selective inhibitor of exportin 1, presents a promising mechanism-based therapeutic approach. Both preclinical and clinical evidence suggest synergistic antileukemic effects when selinexor used in …
cn
(code pays fourni par la source)
Accès ouvert
2025
conference-abstract
OpenAlex
Qi Wang, Miao Chen, Junling Zhuang, Chen Yang et autres
Abstract Background There are unmet needs for patients with warm antibody autoimmune haemolytic anaemia (wAIHA) and Evans syndrome (ES) who are refractory/relapsed to steroids or other second or third line therapies. Mammalian target of rapamycin(mTOR) inhibitor sirolimus has been demonstrated effective in …
cn
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Miao Chen, Amit Sharma, Johann Michler, Xavier Maeder et autres
Disordered metasurfaces offer unique properties unattainable with periodic or ordered metasurfaces, notably the absence of deterministic interference effects at specific wavelengths and angles. In this work, we introduce a lithography-free nanofabrication approach to realize cascaded disordered plasmonic metasurfaces with submicrometer total thickness. …
fr, ca, ch, no, us
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Xiaomin Ye, Miao Chen, Haofan Chen, Xinmiao Lin
BACKGROUND: Premature ovarian failure (POF) is a gynecological endocrine disorder with current treatments having limitations. Kuntai capsule (KTC), a traditional Chinese medicine formulation, is thought to be beneficial for POF, but its mechanism is unclear. Network pharmacology can help explore drug mechanisms. …
cn
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Leyu Wang, Lei Ye, Xin Zhao, Miao Chen et autres
This trial compared antithymocyte globulin (ATG) + cyclosporine A (CsA) + avatrombopag (AVA) and CsA + AVA in older adults with severe aplastic anemia (SAA). The patients were randomized to receive either ATG + CsA + AVA or CsA + AVA. Of …
cn
(code pays fourni par la source)